These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3165308)

  • 41. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
    Ogutu EO; Amayo EO; Okoth F; Lule GN
    East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiology and pathologic results of chronic carriers state of hepatitis B in Mali].
    Maupas P; Chiron JP; Goudeau A; Coursaget P; Perrin J; Barin F; Yvonnet B; Dubois F; Duflo B; Duflo-Moreau B; Sidibe S; Diallo AN
    Bull Soc Pathol Exot Filiales; 1981; 74(6):722-32. PubMed ID: 7343138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABO blood groups distribution in relation to hepatitis B surface antigen and the presence of lipoidophil antibodies.
    Emeribe AO; Ejezie GC
    East Afr Med J; 1992 Mar; 69(3):146-8. PubMed ID: 1505403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research on a new hepatitis B antigen-antibody system: e-anti-e.
    Ortona L; Pizzigallo E; Federico G; Camilli G; Scian J
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):467-75. PubMed ID: 597398
    [No Abstract]   [Full Text] [Related]  

  • 46. Nonspecific test reaction for antibodies to hepatitis B surface antigen in chronic HBAg carriers.
    Vyas GN; Roberts I; Peterson DL; Holland PV
    J Lab Clin Med; 1977 Feb; 89(2):428-32. PubMed ID: 833479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Province of origin of hepatitis B surface antigen carriers among blood donors in Port Moresby.
    Iga T; Babona DV; Nurse GT
    Asia Pac J Public Health; 1989; 3(3):237-41. PubMed ID: 2620026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [HBs antigen in the blood donors of Calvados. Epidemiologic study and surveillance of the patients].
    Arsène D; Verwaerde JC; Rideau A; Sassier JC; Valla A; Thomas M
    Rev Fr Transfus Immunohematol; 1983 Feb; 26(1):45-65. PubMed ID: 6857090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Research on anti-LAV antibodies and HBs antigens in certain population groups in Madagascar].
    Mathiot C; Coulanges P; Rakotondraibe J; Pique G
    Arch Inst Pasteur Madagascar; 1987; 53(1):129-31. PubMed ID: 3482779
    [No Abstract]   [Full Text] [Related]  

  • 50. Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.
    Desaules M; Frei PC; Libanska J; Wuilleret B
    J Infect Dis; 1976 Nov; 134(5):505-9. PubMed ID: 993619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Follow-up studies of healthy blood donors. Anti-HBs antibody carriers.
    Slusarczyk J; Cianciara J; Swiderska H; Loch T
    Vox Sang; 1981 Feb; 40(2):91-4. PubMed ID: 7233887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of Australia antigen in blood donors from Saigon (Vietnam)].
    Doury JC; Capdevielle P; Doury F
    Bull Soc Pathol Exot Filiales; 1977; 70(1):37-42. PubMed ID: 579329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of e-antigen in patients with HBs Ag-positive liver diseases and blood donors.
    Sabău M
    Virologie; 1977; 28(2):159. PubMed ID: 867807
    [No Abstract]   [Full Text] [Related]  

  • 54. Serial liver biopsies in blood donors with persistent HBs antigenaemia.
    Tapp E; Jones DM; Hollanders D; Dymock IW
    J Clin Pathol; 1976 Oct; 29(10):884-6. PubMed ID: 977761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the quality of the principal kits to identify HBs antigen used in French blood transfusion centers. "Viral hepatitis" group of the SNTS].
    Maniez-Montreuil M; Agulles O; Couroucé AM; Janot C
    Rev Fr Transfus Hemobiol; 1991 Dec; 34(6):465-74. PubMed ID: 1772529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the prevalence of 3 markers (HIV antibodies, anti-treponema antibodies, HBs antigen) of sexually transmitted diseases in so-called "at risk" subjects in Madagascar].
    Genin C; Mouden JC; Coulanges P; Randriambololona R; Cassel-Beraud AM; Michel P; Croquet O
    Arch Inst Pasteur Madagascar; 1988; 54(1):197-216. PubMed ID: 3071979
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical and morphological evaluation of hepatic changes in volunteer blood donors, carriers of HB antigen].
    Gajda A; Chrostowska H; Stolarczyk J
    Pol Arch Med Wewn; 1978 May; 59(5):503-11. PubMed ID: 673889
    [No Abstract]   [Full Text] [Related]  

  • 58. Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer.
    Oshima A; Tsukuma H; Hiyama T; Fujimoto I; Yamano H; Tanaka M
    Int J Cancer; 1984 Dec; 34(6):775-9. PubMed ID: 6511124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Liver status in volunteer blood donors carrying HBs antigen].
    Pop-Hristov H; Obradović M; Madzar V; Dalanović Z; Koćovski S; Dimovski C
    Vojnosanit Pregl; 1979; 36(1):20-2. PubMed ID: 462834
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV antigen screening in blood donors.
    Bäcker U; Weinauer F; Gathof G; Eberle J
    Lancet; 1987 Nov; 2(8569):1213-4. PubMed ID: 2890840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.